← Open Payments lookup

KATIE CLARKSON: Open Payments

NPI 1497927297 · ABERDEEN, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$635 in 32 payments from 9 companies in 2025. Trend: 2023 $389 · 2024 $561 · 2025 $635

Food & beverage: $635
CompanyPaymentsAmount
GlaxoSmithKline, LLC.8$179
Amgen Inc.11$170
PFIZER INC.3$74
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$68
AstraZeneca Pharmaceuticals LP2$41
Viatris Specialty LLC2$40
Phathom Pharmaceuticals, Inc.1$26
Abbott Laboratories1$21
Lilly USA, LLC1$18

Products named: TRELEGY ELLIPTA, OTEZLA, XIFAXAN, PAXLOVID, AIRSUPRA, YUPELRI, REPATHA, PREVNAR 20.

Industry payments across WA — which companies pay providers there.